Innate Pharma announces its participation in upcoming investor conferences

Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) today announced members of its executive team are scheduled to participate in the upcoming conferences, detailed below. Participants will include Hervé Brailly, Chief Executive Officer, Sonia Quaratino, Executive Vice President (EVP), Chief Medical Officer, Yannis Morel, EVP, Chief Operating Officer and Arvind Sood, EVP, President of US Operations.

Jefferies Global Healthcare Conference 
Event dates: June 5-6, 2024 | New York, United States

Goldman Sachs 45th Annual Global Healthcare Conference
Event dates: June 10-13, 2024 | Miami, United States

H.C. Wainwright 2nd Annual Immune Cell Engager Virtual Conference
Event date: June 25, 2024 | Virtual

Stifel 2nd European Healthcare Summit Lyon
Event dates: June 25-27, 2024 | Lyon, France